OS Therapies Inc SEC filings OSTX
OS Therapies Inc has 243 filings in SEC EDGAR's recent list, going back to Dec 5, 2019. Its latest annual report, Form ARS, was filed on Jul 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Oct 5, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 21, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 12, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 6, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Agreement ended
|
Jul 29, 2026 | Jul 23, 2026 |
| 8-K/A | Amended current report | Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Other events
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 2, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 6, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Feb 13, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 12, 2026 | Jan 10, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 21, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Other events
|
Sep 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Agreement ended, Other events
|
Aug 26, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 19, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 15, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 24, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 16, 2025 | May 16, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Other events
|
Apr 15, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Other events
|
Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jan 29, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Other events
|
Jan 15, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 14, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 30, 2024 | Dec 24, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 1, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Other events
|
Aug 22, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 15, 2024 |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OSTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1795091
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.